Cargando…

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

SIMPLE SUMMARY: This study is the first to confirm that the clinical prognostic stage in the American Joint Committee on Cancer (AJCC) 8th edition provides a more accurate prognostication for inflammatory breast cancer than the traditional anatomic stage. It indicated that incorporating biological f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kida, Kumiko, Hess, Kenneth R., Lim, Bora, Iwase, Toshiaki, Chainitikun, Sudpreeda, Valero, Vicente, Lucci, Anthony, Le-Petross, Huong Carisa, Woodward, Wendy A., Krishnamurthy, Savitri, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690918/ https://www.ncbi.nlm.nih.gov/pubmed/33114311 http://dx.doi.org/10.3390/cancers12113105

Ejemplares similares

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
por: Chainitikun, Sudpreeda, et al.
Publicado: (2021)

Update on systemic treatment for newly diagnosed inflammatory breast cancer
por: Chainitikun, Sudpreeda, et al.
Publicado: (2020)

Targeting Signaling Pathways in Inflammatory Breast Cancer
por: Wang, Xiaoping, et al.
Publicado: (2020)

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
por: Iwase, Toshiaki, et al.
Publicado: (2021)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2019)

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
por: Ueno, Naoto T., et al.
Publicado: (2018)

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
por: Lee, Jangsoon, et al.
Publicado: (2021)

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood
por: Wylie, Dennis, et al.
Publicado: (2023)

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(®) in patients with breast cancer treated with primary systemic therapy
por: Le Du, Fanny, et al.
Publicado: (2020)

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
por: Krishnamurthy, Savitri, et al.
Publicado: (2013)

The Committee Stage of the National Insurance Bill
Publicado: (1911)

The Committee Stage of the National Insurance Bill
Publicado: (1911)

The Committee Stage of the National Insurance Bill
Publicado: (1911)

Inflammatory breast cancer appearance at presentation is associated with overall survival
por: Balema, Wintana, et al.
Publicado: (2021)

Aldehyde Dehydrogenase1 Immunohistochemical Staining in Primary Breast Cancer Cells Independently Predicted Overall Survival But Did Not Correlate with the Presence of Circulating or Disseminated Tumors Cells
por: Woodward, Wendy A., et al.
Publicado: (2014)

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
por: Fouad, Tamer M., et al.
Publicado: (2018)

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
por: Villodre, Emilly S., et al.
Publicado: (2021)

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
por: Murthy, Rashmi K., et al.
Publicado: (2020)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
por: Villodre, Emilly S., et al.
Publicado: (2020)

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2022)

American joint committee on cancer staging of uveal melanoma
por: Mellen, Phoebe L., et al.
Publicado: (2013)

Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool
por: Krishnamurthy, Savitri, et al.
Publicado: (2023)

Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
por: Abuhadra, Nour, et al.
Publicado: (2022)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis
por: Su, Fei, et al.
Publicado: (2020)

Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial
por: Abuhadra, Nour, et al.
Publicado: (2023)

The Role of (18)F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast Cancer
por: Niikura, Naoki, et al.
Publicado: (2010)

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
por: Lim, Bora, et al.
Publicado: (2019)

Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8(th) Edition) staging system for pancreatic cancer
por: Yu, Hai-Feng, et al.
Publicado: (2018)

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
por: Xie, Xuemei, et al.
Publicado: (2023)

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
por: Debeb, Bisrat G, et al.
Publicado: (2010)

Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging
por: Tomar, Ankit Singh, et al.
Publicado: (2023)

Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma
por: Wang, Yu‐Ting, et al.
Publicado: (2023)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p66mqljsdeqc7refn4em929qt8